tiprankstipranks
Trending News
More News >
Newron Pharmaceuticals SpA (CH:NWRN)
:NWRN
Switzerland Market

Newron Pharmaceuticals SpA (NWRN) Stock News & Sentiment

Compare
0 Followers
Newron Pharmaceuticals Reports Strong 2024 Results and Strategic Growth Plans for 2025
Premium
Company Announcements
Newron Pharmaceuticals Reports Strong 2024 Results and Strategic Growth Plans for 2025
8d ago
Newron Pharmaceuticals SpA ( ($CH:NWRN) ) has provided an announcement. Newron Pharmaceuticals reported significant progress in 2024, highlighted by promising data from studies on Evenamide, a potential treatment for schizophrenia. ...Read more
Newron Pharmaceuticals Reports Profit and Strategic Advances in 2024
Premium
Company Announcements
Newron Pharmaceuticals Reports Profit and Strategic Advances in 2024
8d ago

News Score - Last 7 Days

Neutral
CH:NWRN
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average62%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CH:NWRN’s Media Buzz Sentiment?
Currently, no data Available
What is CH:NWRN’s weekly average amount of articles?
Currently, no data Available
What is CH:NWRN’s News Sentiment?
50% of articles about CH:NWRN were positive this week, compared to its sector average of 62%.
    Healthcare Stocks that are Trending in the News
    RYTMRhythm Pharmaceuticals
    WBAWalgreens Boots Alliance
    UNHUnitedHealth
    SLPSimulations Plus
    TMDXTransMedics Group
    Showing the stocks with the most bullish news sentiment over the past week
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis